Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

iBio (IBIO) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for iBio (IBIO) over the last 17 years, with Q4 2025 value amounting to 0.44%.

  • iBio's Return on Capital Employed rose 4100.0% to 0.44% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.44%, marking a year-over-year increase of 4100.0%. This contributed to the annual value of 0.94% for FY2025, which is 4000.0% down from last year.
  • iBio's Return on Capital Employed amounted to 0.44% in Q4 2025, which was up 4100.0% from 0.54% recorded in Q3 2025.
  • iBio's 5-year Return on Capital Employed high stood at 0.18% for Q1 2021, and its period low was 1.45% during Q4 2023.
  • For the 5-year period, iBio's Return on Capital Employed averaged around 0.74%, with its median value being 0.61% (2024).
  • Per our database at Business Quant, iBio's Return on Capital Employed tumbled by -10900bps in 2023 and then soared by 9500bps in 2024.
  • iBio's Return on Capital Employed (Quarter) stood at 0.23% in 2021, then crashed by -282bps to 0.88% in 2022, then crashed by -65bps to 1.45% in 2023, then skyrocketed by 42bps to 0.85% in 2024, then skyrocketed by 48bps to 0.44% in 2025.
  • Its last three reported values are 0.44% in Q4 2025, 0.54% for Q3 2025, and 1.24% during Q2 2025.